Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 3/20 | 0.46 |
| ▸ | THRB | P10828 | 2/20 | 0.46 |
| ▸ | GMNN | O75496 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | FAAH | O00519 | 4/20 | 0.41 |
| ▸ | CES1 | P23141 | 4/20 | 0.41 |
| ▸ | PLA2G6 | O60733 | 1/20 | 0.41 |
| ▸ | PRKD3 | O94806 | 2/20 | 0.37 |
| ▸ | PRKCG | P05129 | 2/20 | 0.37 |
| ▸ | PRKCB | P05771 | 2/20 | 0.37 |
| ▸ | PRKCA | P17252 | 2/20 | 0.37 |
| ▸ | PRKCH | P24723 | 2/20 | 0.37 |
| ▸ | PRKCI | P41743 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5892194 | 1.00 | CES2 (0.46) | CES2THRBGMNNTP53POLB | |
| SCHEMBL7838993 | 1.00 | CES2 (0.46) | CES2THRBGMNNTP53POLB | |
| SCHEMBL16892523 | 1.00 | CES2 (0.46) | CES2THRBGMNNTP53POLB | |
| SCHEMBL11692190 | 1.00 | CES2 (0.46) | CES2THRBGMNNTP53POLB | |
| SCHEMBL7839304 | 1.00 | CES2 (0.46) | CES2THRBGMNNTP53POLB | |
| SCHEMBL9312687 | 1.00 | CES2 (0.46) | CES2THRBGMNNTP53POLB | |
| SCHEMBL7829248 | 1.00 | CES2 (0.46) | CES2THRBGMNNTP53POLB | |
| SCHEMBL11529157 | 1.00 | CES2 (0.46) | CES2THRBGMNNTP53POLB | |
| SCHEMBL5042153 | 1.00 | CES2 (0.46) | CES2THRBGMNNTP53POLB | |
| SCHEMBL17415841 | 1.00 | CES2 (0.46) | CES2THRBGMNNTP53POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5338642-A | Diazo type recording material comprising two couplers wherein the novel coupler used is a bis-malonamide | FUJI PHOTO FILM CO., LTD. (JP) | 1994-08-16 | — | — | US | claimed |
| CN-118317944-A | Acyclic lipids and methods of use thereof | 雷纳嘉德医疗管理公司 | 2024-07-09 | — | — | CN | disclosed |
| CN-118234707-A | Cyclic lipids and methods of use thereof | 雷纳嘉德医疗管理公司 | 2024-06-21 | — | — | CN | disclosed |
| US-10548911-B2 | Small molecule anti-scarring agents | UNIVERSITY OF ROCHESTER (US) | 2020-02-04 | — | — | US | disclosed |
| EP-2894685-B1 | BENZOTHIENOBENZOTHIOPHENE DERIVATIVE, ORGANIC SEMICONDUCTOR MATERIAL, AND ORGANIC TRANSISTOR | DAINIPPON INK & CHEMICALS (JP) | 2018-10-31 | — | — | EP | disclosed |
| EP-2978768-B1 | CATALYTIC PROCESS FOR THE PREPARATION OF THIOCARBOXYLATE SILANE | MOMENTIVE PERFORMANCE MAT INC (US) | 2017-11-29 | — | — | EP | disclosed |
| US-20170216332-A1 | SMALL MOLECULE ANTI-SCARRING AGENTS | UNIVERSITY OF ROCHESTER (US) | 2017-08-03 | — | — | US | disclosed |
| US-20170204076-A1 | SYNTHESIS AND USE OF AMINO LIPIDS | SCREENFECT GMBH (DE) | 2017-07-20 | — | — | US | disclosed |
| US-9490433-B2 | Benzothienobenzothiophene derivative, organic semiconductor material, and organic transistor | DIC CORPORATION (JP) | 2016-11-08 | — | — | US | disclosed |
| EP-2978768-A1 | CATALYTIC PROCESS FOR THE PREPARATION OF THIOCARBOXYLATE SILANE | Momentive Performance Materials Inc. (US) | 2016-02-03 | — | — | EP | disclosed |
| US-4322527-A | 6-Amino-dibenz[d,g][1,3,2]dioxaphosphocines | CIBA-GEIGY CORPORATION (US) | 1982-03-30 | — | — | US | disclosed |
| US-4301061-A | STABILIZERS | CIBA-GEIGY CORPORATION (US) | 1981-11-17 | — | — | US | disclosed |
| US-4297492-A | STABILIZERS FOR PLASTICS | CIBA-GEIGY CORPORATION (US) | 1981-10-27 | — | — | US | disclosed |
| EP-0005500-B1 | DIOXAPHOSPHEPINES, THEIR PREPARATION AND USE AS STABILISERS FOR ORGANIC MATERIALS | CIBA-GEIGY AG (CH) | 1981-10-07 | — | — | EP | disclosed |
| US-4259492-A | STABILIZERS FOR PLASTICS AND ELASTOMERS | CIBA-GEIGY CORPORATION (US) | 1981-03-31 | — | — | US | disclosed |
| EP-0020297-A1 | Cyclic phosphoric acid ester amides, process for their preparation and their use as stabilizers | CIBA-GEIGY AG (CH) | 1980-12-10 | — | — | EP | disclosed |
| EP-0007758-A1 | Alkyl ammonium ionomers | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1980-02-06 | — | — | EP | disclosed |
| EP-0005441-A1 | Aminodibenzoxaphosphorines, process for their preparation and their use as stabilisators | CIBA-GEIGY AG (CH) | 1979-11-28 | — | — | EP | disclosed |
| EP-0005500-A1 | Dioxaphosphepines, their preparation and use as stabilisers for organic materials | CIBA-GEIGY AG (CH) | 1979-11-28 | — | — | EP | disclosed |
| US-3944632-A | Phosphoric acid anilides | CIBA-GEIGY CORPORATION (US) | 1976-03-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170216332-A1 | SMALL MOLECULE ANTI-SCARRING AGENTS | COLGALT1, MMP1, FIBP | CES2 2403/4885THRB 2211/4885GMNN 3176/4885 |
| US-10548911-B2 | Small molecule anti-scarring agents | COLGALT1, MMP1, FIBP | CES2 2403/4885THRB 2211/4885GMNN 3176/4885 |
| US-20170204076-A1 | SYNTHESIS AND USE OF AMINO LIPIDS | ACSL4, PYM1, LPAR4 | CES2 879/4885THRB 3696/4885GMNN 1832/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.